[Treatment and prognosis of pT2 endometrial carcinoma]
other
public-domain-us
AI-generated summary
This retrospective study of 66 patients with pT2 endometrial carcinoma found cervical stromal invasion and deeper myometrial invasion significantly decreased survival, while histologic grade did not.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Between January, 1966 and December, 1988, 66 patients with surgical-pathological stage II adenocarcinoma of the endometrium who were treated with abdominal simple or radical hysterectomy at the Osaka National Hospital were studied retrospectively. The 5-year survival rate for all patients was 75.7%. In 33 patients adenocarcinoma had invaded the cervical stroma. These patients demonstrated a significantly lower survival (60.0%) than those patients whose involvement was limited to the endocervical gland (91.7%) (p less than 0.05). For all patients, both with endocervical glandular involvement and cervical stromal invasion, radical hysterectomy improved survival rates more than did simple hysterectomy, but the difference was not statistically significant. The factor found to have a significant influence on survival was the maximal depth of invasion of the myometrium (p less than 0.05). The histologic grade, on the other hand, did not appear to influence survival. It is suggested that patients with minimal involvement of the cervix can be satisfactorily treated with simple hysterectomy, while patients with gross cervical spread should be treated with radical hysterectomy.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-06-17T06:13:18.893374+00:00
- pubmed
- last seen: 2026-05-13T22:12:00.397535+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine